Measurement properties of the benign prostatic hyperplasia impact index in tadalafil studies

Abstract

BACKGROUND To assess the measurement properties of the Benign Prostatic Hyperplasia Impact Index (BII) for use in men with Lower Urinary Tract Symptoms (LUTS) secondary to Benign Prostatic Hyperplasia (BPH) treated with tadalafil. METHODS Data from a dose-titration (Study 1) and a dose-finding placebo-controlled (Study 2) tadalafil studies of men 45 years… (More)
DOI: 10.1186/1477-7525-8-131

3 Figures and Tables

Topics

  • Presentations referencing similar topics